-
Loading metrics
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol
-
Devki D. Sukhtankar ,
Contributed equally to this work with: Devki D. Sukhtankar, Juan José Fung
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation GPCR Therapeutics USA, Inc., Redwood City, California, United States of America
⨯ - Juan José Fung ,
- Mi-na Kim,
- Thomas Cayton,
- Valerie Chiou,
- Niña G. Caculitan,
- Piotr Zalicki,
- Sujeong Kim,
- Yoonjung Jo,
- SoHui Kim,
- Jae Min Lee,
- Junhee Choi,
- SeongGyeong Mun,
- Ashley Chin,
- Yongdae Jang,
- Ji Yeong Lee,
- Gowoon Kim,
- Eun Hee Kim,
- Won-Ki Huh,
- Jae-Yeon Jeong,
- Dong-Seung Seen,
- [ ... ],
-
Pina M. Cardarelli
Roles Conceptualization, Investigation, Supervision, Writing – review & editing
* E-mail: pina.cardarelli@gpcrtx.com
Affiliation GPCR Therapeutics USA, Inc., Redwood City, California, United States of America
⨯ - [ view all ]
- [ view less ]
https://orcid.org/0000-0002-3883-2385
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol
- Devki D. Sukhtankar,
- Juan José Fung,
- Mi-na Kim,
- Thomas Cayton,
- Valerie Chiou,
- Niña G. Caculitan,
- Piotr Zalicki,
- Sujeong Kim,
- Yoonjung Jo,
- SoHui Kim
x
- Published: October 25, 2023
- https://doi.org/10.1371/journal.pone.0287863